Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
51.12%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth51.12%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-44.37%
20%
—
—
Never
—
5 Years
Score—
Net Growth-44.37%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Cellectar Biosciences Inc fundamental performance
Across Cellectar Biosciences Inc's full reported history, from 2005 to 2025, revenue declined from $ 12.58K to $ 0.00 and net income went from -$ 3M to -$ 21M. Revenue increased in 6% of the years measured; net income in 30%.
Cellectar Biosciences Inc currently holds a 20-year HDB Score of 1.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.60 | — |
1 Year2025-08-12 | $ 4.61 | -43.60% |
5 Years2021-08-12 | $ 258.57 | -98.99% |
10 Years2016-08-12 | $ 8.85K | -99.97% |
20 Years2006-08-11 | $ 1000K | -100.00% |
All Time2005-11-10 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2005-11-10 |
|---|---|---|---|---|---|---|
| Price | $ 2.60 | $ 4.61 | $ 258.57 | $ 8.85K | $ 1000K | $ 1000K |
| Return | — | -43.60% | -98.99% | -99.97% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 21M | $ 13M |
| 2024 | $ 0.00 | -$ 44M | $ 23M |
| 2023 | $ 0.00 | -$ 42M | $ 9M |
| 2022 | $ 0.00 | -$ 28M | $ 19M |
| 2021 | $ 0.00 | -$ 23M | $ 35M |
| 2020 | $ 0.00 | -$ 15M | $ 57M |
| 2019 | $ 0.00 | -$ 14M | $ 10M |
| 2018 | $ 0.00 | -$ 13M | $ 13M |
| 2017 | $ 0.00 | -$ 13M | $ 10M |
| 2016 | $ 0.00 | -$ 6M | $ 11M |
| 2015 | $ 0.00 | -$ 5M | $ 3M |
| 2014 | $ 0.00 | -$ 8M | $ 9M |
| 2013 | $ 0.00 | -$ 10M | $ 2M |
| 2012 | $ 0.00 | -$ 8M | $ 4M |
| 2011 | -$ 11K | -$ 7M | $ 5M |
| 2010 | $ 33.33K | $ 2M | $ 2M |
| 2009 | $ 96.31K | -$ 22M | $ 8M |
| 2008 | $ 125.97K | -$ 16M | $ 1M |
| 2007 | -$ 19M | $ 9M | |
| 2006 | $ 12.58K | -$ 8M | $ 9M |
| IPO2005 | $ 12.58K | -$ 3M | $ 4M |
Explore beyond CLRB
You're looking at Cellectar Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
